| Product Code: ETC10557006 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
India`s import shipments of disease-modifying agents in 2024 saw a significant increase in concentration, with top exporters being Germany, USA, Switzerland, Australia, and Italy. The Herfindahl-Hirschman Index (HHI) indicated a shift from very high concentration in 2023 to high concentration in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 5.59%, while the growth rate from 2023 to 2024 surged to 19.95%. This data underscores the growing importance and demand for disease-modifying agents in the Indian market, with key players continuing to dominate the import landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Disease Modifying Agents Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Disease Modifying Agents Market Revenues & Volume, 2021 & 2031F |
3.3 India Disease Modifying Agents Market - Industry Life Cycle |
3.4 India Disease Modifying Agents Market - Porter's Five Forces |
3.5 India Disease Modifying Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Disease Modifying Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Disease Modifying Agents Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 India Disease Modifying Agents Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.9 India Disease Modifying Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Disease Modifying Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India |
4.2.2 Growing awareness about the importance of early disease diagnosis and treatment |
4.2.3 Rising healthcare expenditure and insurance coverage in the country |
4.3 Market Restraints |
4.3.1 High cost of disease modifying agents leading to affordability issues for a significant portion of the population |
4.3.2 Lack of skilled healthcare professionals for proper diagnosis and treatment of diseases |
4.3.3 Regulatory challenges and stringent approval processes for new disease modifying agents in India |
5 India Disease Modifying Agents Market Trends |
6 India Disease Modifying Agents Market, By Types |
6.1 India Disease Modifying Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Disease Modifying Agents Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Disease Modifying Agents Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 India Disease Modifying Agents Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 India Disease Modifying Agents Market Revenues & Volume, By Gene Therapies, 2021 - 2031F |
6.2 India Disease Modifying Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Disease Modifying Agents Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.2.3 India Disease Modifying Agents Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.4 India Disease Modifying Agents Market Revenues & Volume, By Genetic Diseases, 2021 - 2031F |
6.3 India Disease Modifying Agents Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 India Disease Modifying Agents Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.3.3 India Disease Modifying Agents Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.4 India Disease Modifying Agents Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.4 India Disease Modifying Agents Market, By Form |
6.4.1 Overview and Analysis |
6.4.2 India Disease Modifying Agents Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.3 India Disease Modifying Agents Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.4.4 India Disease Modifying Agents Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5 India Disease Modifying Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Disease Modifying Agents Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 India Disease Modifying Agents Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 India Disease Modifying Agents Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 India Disease Modifying Agents Market Import-Export Trade Statistics |
7.1 India Disease Modifying Agents Market Export to Major Countries |
7.2 India Disease Modifying Agents Market Imports from Major Countries |
8 India Disease Modifying Agents Market Key Performance Indicators |
8.1 Average time taken for diagnosis and initiation of treatment |
8.2 Number of healthcare facilities offering disease modifying agents treatment |
8.3 Patient adherence rate to prescribed disease modifying agents |
9 India Disease Modifying Agents Market - Opportunity Assessment |
9.1 India Disease Modifying Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Disease Modifying Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Disease Modifying Agents Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 India Disease Modifying Agents Market Opportunity Assessment, By Form, 2021 & 2031F |
9.5 India Disease Modifying Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Disease Modifying Agents Market - Competitive Landscape |
10.1 India Disease Modifying Agents Market Revenue Share, By Companies, 2024 |
10.2 India Disease Modifying Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here